EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma NCT00004261 Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 Years University Health Network, Toronto View EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer NCT00041028 Lung Cancer
EF5
flow cytometry
immunohistochem...
18 Years - National Cancer Institute (NCI) View Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients NCT00026975 Laryngeal Cance...
Hyperbaric Oxyg...
18 Years - National Center for Complementary and Integrative Health (NCCIH) View Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors NCT00110032 Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Grade III...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Supratent...
Meningeal Melan...
EF5
conventional su...
positron emissi...
fluorine F 18 E...
pharmacological...
18 Years - National Cancer Institute (NCI) View EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191 Advanced Adult ...
Carcinoma of th...
Fallopian Tube ...
Gastrointestina...
Localized Extra...
Localized Gallb...
Localized Gastr...
Localized Resec...
Localized Unres...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Primary Periton...
Recurrent Adult...
Recurrent Adult...
Recurrent Colon...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Small Intestine...
Small Intestine...
Small Intestine...
Stage 0 Non-sma...
Stage I Adult S...
Stage I Colon C...
Stage I Gastric...
Stage I Non-sma...
Stage I Ovarian...
Stage I Ovarian...
Stage I Pancrea...
Stage I Rectal ...
Stage I Uterine...
Stage II Adult ...
Stage II Colon ...
Stage II Gastri...
Stage II Non-sm...
Stage II Ovaria...
Stage II Ovaria...
Stage II Pancre...
Stage II Rectal...
Stage II Uterin...
Stage III Adult...
Stage III Colon...
Stage III Gastr...
Stage III Ovari...
Stage III Ovari...
Stage III Pancr...
Stage III Recta...
Stage III Uteri...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Adult ...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Uterin...
Unresectable Ex...
Unresectable Ga...
EF5
motexafin lutet...
pharmacological...
18 Years - National Cancer Institute (NCI) View Imaging and Biomarkers of Hypoxia in Solid Tumors NCT01123005 Neoplasms
PET Scan
EF5
Carbogen
Dichloroacetate
18 Years - Stanford University View Imaging and Biomarkers of Hypoxia in Solid Tumors NCT01123005 Neoplasms
PET Scan
EF5
Carbogen
Dichloroacetate
18 Years - Stanford University View Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers NCT01163487 Head and Neck C...
Head and Neck C...
Dichloroacetate
EF5
18 Years - Stanford University View EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer NCT02154399 Stage IA Non-Sm...
Stage IB Non-Sm...
Stage IIA Non-S...
Stage IIB Non-S...
Stage IIIA Non-...
Stage IIIB Non-...
EF5
Laboratory Biom...
Therapeutic Con...
Tissue Oxygen M...
18 Years - National Cancer Institute (NCI) View EF5 in Treating Patients With Solid Tumors NCT00003282 Unspecified Adu...
EF5
therapeutic con...
biopsy
pharmacological...
18 Years - National Cancer Institute (NCI) View EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer NCT00107445 Primary Periton...
Stage I Endomet...
Stage I Ovarian...
Stage IA Cervic...
Stage IB Cervic...
Stage II Endome...
Stage II Ovaria...
Stage IIA Cervi...
Stage IIB Cervi...
Stage III Cervi...
Stage III Endom...
Stage III Ovari...
Stage IV Endome...
Stage IV Ovaria...
Stage IVA Cervi...
Stage IVB Cervi...
EF5
18 Years - National Cancer Institute (NCI) View EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer NCT00049140 Head and Neck C...
EF5
bioluminescence
flow cytometry
immunohistochem...
biopsy
18 Years - Duke University View EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma NCT00004261 Breast Cancer
Cervical Cancer
Head and Neck C...
Prostate Cancer
Sarcoma
EF5
flow cytometry
fluorescent ant...
immunohistochem...
biopsy
18 Years - 120 Years University Health Network, Toronto View To Evaluate the Characteristics of a Breast Cancer NCT01055678 Breast Cancer
EF5
Partial or Tota...
18 Years - Duke University View EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer NCT00049231 Cervical Cancer
EF5
immunohistochem...
biopsy
18 Years - National Cancer Institute (NCI) View EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer NCT00896961 Stage I Adult S...
Stage I Squamou...
Stage II Adult ...
Stage II Squamo...
Stage III Adult...
Stage III Squam...
EF5
diagnostic labo...
pharmacological...
18 Years - National Cancer Institute (NCI) View EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer NCT00896961 Stage I Adult S...
Stage I Squamou...
Stage II Adult ...
Stage II Squamo...
Stage III Adult...
Stage III Squam...
EF5
diagnostic labo...
pharmacological...
18 Years - National Cancer Institute (NCI) View